▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / KOAN

KOAN — Resonate Blends, Inc.

—
OTC · Information Technology · Software · CIK 897078 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Resonate Blends, Inc. engages in the discovery, development, and marketing of products for mankind in the field of regenerative medicine. It focuses on marketing licensed patent-pending natural stem cell mobilizing agents for enhancing individual's ability to mobilize their own adult stem cells from their bone marrow. The company also has a license to market a dual acting all-natural diet aid to help control hunger through normal body signals to the brain and stomach. In addition, it is involved in the research and development activities focusing on exploring other areas, such as Secretogues to enhance a person's own growth hormone production and similar natural bioactive formulations to enhance human performance utilizing known body mechanisms without the use of drugs. The company is based in North Bergen, New Jersey.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 242,355 167,027 -273,719 -966,899 2,563,576 216,895 8,188,484
Jun 2025 452,314 290,118 -206,940 -486,824 1,016,607 13,433 5,467,525
Mar 2025 430,768 290,043 -330,242 -411,818 1,202,091 18,117 5,418,185
Dec 2024 546,310 363,365 -350,664 -577,441 1,854,461 8,048 5,054,040

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,089,145
Investing CF
$0
Financing CF
$1,210,279
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-31,568,796
Inventory
—
Receivables
$555,998
ST Investments
—
EBIT TTM
$-1,149,220
Pretax Income TTM
$-2,442,980
Interest Exp TTM
$1,293,760
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,231,933
EBITDA
$-1,591,510
Free Cash Flow
$-1,657,840
Enterprise Value
$4,237,055
Total Cash
$18,117
Total Debt
$4,157,348
Shares Out
346,314,106
Trailing EPS
$-0.01
Book Value
$-0.02
ROE
—
ROA
-28.2%
Div Yield
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,703,326 -985,115 -1,732,286 2,362,007 7,058,016 — -1,518,510
Dec 2024 1,896,215 -1,697,626 -2,133,208 1,854,461 5,054,040 — -1,029,062
Dec 2023 16,468 -399,223 -1,415,979 992,341 3,127,913 — 11,166
Dec 2022 49,501 -1,389,395 653,627 399,121 1,545,851 — -1,428,467
Dec 2021 — — — — — — —

Peers — same industry

TickerNameMarket CapLastDaily %
MSFT MICROSOFT CORP $3.62T $487.31 —
ORCL ORACLE CORP $410.32B $142.45 —
PLTR Palantir Technologies Inc. $404.67B $175.89 —
SAP SAP SE $252.38B $218.66 —
SAPGF SAP SE $251.62B $218.00 —

News headlines (Yahoo Finance, 1h cache)

Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc.
2026-04-08 13:30 · Yahoo
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System
2026-02-10 15:08 · Yahoo
Apollo Biowellness Executes Letter Of Intent with Medwell AI, Inc.
2026-02-10 14:30 · Yahoo
Apollo Biowellness, Inc., Announces Termination of Distribution Agreement with Revive Regenerative, Inc.
2026-02-06 14:30 · Yahoo
Apollo Biowellness, Inc., to Merge with Revive Regenerative, Inc.
2025-09-17 13:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →